MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BBOT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BridgeBio Oncology Therapeutics (BBOT) Ownership - Who owns BridgeBio Oncology Therapeutics?

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
256 East Grand Avenue
Phone
+1 650 405-4770
Employees
92
Web
https://www.bridgebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
394.46M
P/E Ratio
N/A
Total Cash
225.71M
Projected Growth
N/A
Total Debt
2.51M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
BBOT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for BBOT
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
256 East Grand Avenue
Phone
+1 650 405-4770
Employees
92
Web
https://www.bridgebio.com
Who owns BridgeBio Oncology Therapeutics? BBOT symbol Ownership - Tickeron.com